Similar articles

• Mutation at I-A beta chain prevents experimental autoimmune myasthenia gravis.

  Christadoss P, Lindstrom JM, Melvold RW, Talal N. Christadoss P, et al. Immunogenetics. 1985;21(1):33-8. doi: 10.1007/BF00372239. Immunogenetics. 1985. PMID: 3917973
• T cell receptor gene regulation of experimental autoimmune myasthenia gravis.

  Wu B, Shenoy M, Christadoss P. Wu B, et al. Adv Neuroimmunol. 1994;4(4):433-45. doi: 10.1016/0960-5428(94)00036-n. Adv Neuroimmunol. 1994. PMID: 7536604 Review. No abstract available.
• The immunogenetics of myasthenia gravis, multiple sclerosis and their animal models.

  Tournier-Lasserve E, Bach JF. Tournier-Lasserve E, et al. J Neuroimmunol. 1993 Sep;47(2):103-14. doi: 10.1016/0165-5728(93)90020-y. J Neuroimmunol. 1993. PMID: 8370764 Review. No abstract available.
• Molecular immunopathogenesis of experimental autoimmune myasthenia gravis.

  Christadoss P, Shenoy M. Christadoss P, et al. Reg Immunol. 1992 Sep-Oct;4(5):314-20. Reg Immunol. 1992. PMID: 1337839 Review. No abstract available.
• Immune response gene control of lymphocyte proliferation induced by acetylcholine receptor-specific helper factor derived from lymphocytes of myasthenic mice.

  Christadoss P, Lindstrom JM, Talal N, Duvic CR, Kalantri A, Shenoy M. Christadoss P, et al. J Immunol. 1986 Sep 15;137(6):1845-9. J Immunol. 1986. PMID: 2943805